InfuSystem Holdings, Inc(INFU)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,038 of 2,962 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
INFU Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for InfuSystem Holdings, Inc (INFU), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INFU at 58.2/100 on a 32-signal composite quality model, placing it at rank #1,038 of 2,962 stocks — the top half of the AI-ranked universe. INFU scores in the top quartile across earnings quality (88.9), balance sheet strength (82.4), institutional flow (81.7). Areas of concern include revenue scale (19.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 32.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), InfuSystem Holdings, Inc reports quarterly revenue of $36.9M, net income of $3.2M, an operating margin of 11.2%. Top institutional holders of INFU by reported 13-F value include BlackRock, Minerva Advisors, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, based on the most recent SEC filings. INFU trades on the NYSE exchange and files with the SEC under CIK 1337013. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INFU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InfuSystem Holdings, Inc directly from SEC EDGAR.
Revenue
Q2 2026
$36.9M
Net Income
Q2 2026
$3.2M
Free Cash Flow
Q2 2026
$6.7M
Operating Margin
Q2 2026
11.2%
ROIC
Q2 2026
20.9%
D/E Ratio
Q2 2026
0.35
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+6.4% YoYNet Income
+182.6% YoYOperating Income
+73.0% YoYEPS (Diluted)
+181.8% YoYTotal Assets
-2.9% YoYTotal Debt
-17.8% YoYOp. Cash Flow
+19.3% YoYFree Cash Flow
+23.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $143.4M +6.4% | $134.9M +7.2% | $125.8M +14.4% | $109.9M +7.4% | $102.4M +5.1% | $97.4M |
| Net Income | $6.6M +182.6% | $2.3M +168.9% | $872.0K +4744.4% | $18.0K -98.7% | $1.4M -91.8% | $17.3M |
| Operating Income | $11.9M +73.0% | $6.9M +68.6% | $4.1M +147.2% | $1.7M -41.3% | $2.8M -68.1% | $8.8M |
| EPS (Diluted) | $0.31 +181.8% | $0.11 +175.0% | $0.04 | $0.00 -100.0% | $0.06 -92.5% | $0.80 |
| Total Assets | $100.6M -2.9% | $103.6M +0.7% | $102.9M +3.5% | $99.4M +1.8% | $97.6M +0.6% | $97.0M |
| Total Debt | $19.6M -17.8% | $23.9M -18.0% | $29.1M -12.2% | $33.2M -0.9% | $33.4M -30.6% | $48.2M |
| Operating Cash Flow | $24.4M +19.3% | $20.5M +82.3% | $11.2M -35.9% | $17.5M -4.4% | $18.3M -9.7% | $20.3M |
| Free Cash Flow | $23.8M +23.1% | $19.4M +89.9% | $10.2M -38.3% | $16.5M -4.6% | $17.3M -9.6% | $19.2M |
Get alerted when INFU's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for InfuSystem Holdings, Inc including:
Top Institutional Holders of INFU
BlackRock, Inc.
$15.3M1,585,415 shMinerva Advisors LLC
$13.0M1,348,617 shPUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
$8.1M834,750 shVANGUARD CAPITAL MANAGEMENT LLC
$7.6M790,775 shACADIAN ASSET MANAGEMENT LLC
$7.2M743,155 shHEARTLAND ADVISORS INC
$6.8M700,000 shAMERICAN CENTURY COMPANIES INC
$6.5M675,028 shFirst Eagle Investment Management, LLC
$6.0M620,000 shDIMENSIONAL FUND ADVISORS LP
$5.8M599,289 shRENAISSANCE TECHNOLOGIES LLC
$5.2M543,009 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $15.3M | 1,585,415 |
| Minerva Advisors LLC | $13.0M | 1,348,617 |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $8.1M | 834,750 |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.6M | 790,775 |
| ACADIAN ASSET MANAGEMENT LLC | $7.2M | 743,155 |
| HEARTLAND ADVISORS INC | $6.8M | 700,000 |
| AMERICAN CENTURY COMPANIES INC | $6.5M | 675,028 |
| First Eagle Investment Management, LLC | $6.0M | 620,000 |
| DIMENSIONAL FUND ADVISORS LP | $5.8M | 599,289 |
| RENAISSANCE TECHNOLOGIES LLC | $5.2M | 543,009 |
Companies Similar to INFU
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Electromed, Inc.
PACS Group, Inc.
VIEMED HEALTHCARE, INC.
IRADIMED CORP
NATURES SUNSHINE PRODUCTS INC
IRONWOOD PHARMACEUTICALS INC
CareDx, Inc.
PRO DEX INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put INFU on your watchlist
Track score changes the day InfuSystem Holdings, Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INFU a good stock to buy?
13F Pro's AI-powered analysis of InfuSystem Holdings, Inc (INFU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INFU are available on the INFU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. INFU is classified as a small company.
Which hedge funds own INFU?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INFU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InfuSystem Holdings, Inc's investment landscape.